Company Email Format Management

Belite Bio

Biotechnology Research San Diego, California, United States 21 employees BLTE

Employees: 21
Contacts: 3
Emails: 3
Phones: 1

belitebio.com LinkedIn Crunchbase

Belite Bio Overview

Headquarters: San Diego, California, United States
Website: belitebio.com
Industry: Biotechnology Research
Employees: 21
Founded: 2018
Stock Symbol: BLTE
Funding: 15.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

RBP4 Drug Development Dry Age-Related Macular Degeneration Stargardt Disease Diabetes NASH NAFLD

About Belite Bio

Belite Bio (NASDAQ: BLTE) is a San Diego based clinical stage drug development company targeting untreatable eye diseases, such as dry AMD and Stargardt disease (STGD1) which is the most common inherited retinal dystrophy, and metabolic diseases. Its lead pipeline, Tinlarebant (aka LBS-008), is a novel oral once-a-day tablet intended to treat Dry AMD and STGD1 early. Tinlarebant is in phase 3 and has been granted Fast Track & RPD designation in the US, and ODD in the US and EMA for STGD1.

Belite Bio Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Belite Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tom Lin	Chairman and CEO	Taipei City, Taiwan, United States	Email
Nathan L. Mata, Phd	Chief Scientific Officer - Belite Bio	San Diego, California, United States	Email Phone
Lisa Liang	Senior Director of Clinical Operations	Taipei, Taipei City, Taiwan, Province of China	Email
Hendrik Scholl	Chief Medical Officer (Belite Bio)		View